MedPath

DCS versus DES for One-month DAPT in patients with ACS: ONE-PASS Trial

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0007141
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
3520
Inclusion Criteria

1. Age =19 years
2. All subjects who are acceptable candidates for treatment with a DCS or DES because of ACS
3. Provision of informed consent

Exclusion Criteria

1. Current or potential pregnancy
2. Need of oral anticoagulation therapy
3. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient-oriented composite endpoint (POCE): The composite of all-cause death, MI, or any revascularization
Secondary Outcome Measures
NameTimeMethod
Device-oriented composite endpoint (DOCE): The composite of cardiovascular death, MI (not clearly attributable to a non-target vessel), or clinically-driven target-lesion revascularization (TLR);All-cause death;Cardiovascular death;Myocardial infarction;Stroke;Stent thrombosis (definite or probable);Any revascularization;Target-vessel revascularization;Non-target vessel revascularization;Target-lesion revascularization;BARC type 2-5 bleeding;BARC type 3-5 bleeding
© Copyright 2025. All Rights Reserved by MedPath